Sulfonamide derivatives for the treatment of diseases

Details for Australian Patent Application No. 2005214153 (hide)

Owner Pfizer Inc.

Inventors Brown, Alan Daniel; Price, David Anthony; Thomson, Nicholas Murray; Bunnage, Mark Edward; Glossop, Paul Alan; Moses, Ian Brian; Lane, Charlotte Alice Louise; James, Kim; Lewthwaite, Russell Andrew

Agent Shelston IP

Pub. Number AU-B-2005214153

PCT Pub. Number WO2005/080313

Priority 60/600,260 09.08.04 US; 0406387.1 22.03.04 GB; 04290169.4 22.01.04 EP

Filing date 12 January 2005

Wipo publication date 1 September 2005

Acceptance publication date 18 September 2008

International Classifications

C07C 311/08 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/080313 Priority application(s): WO2005/080313

18 September 2008 Application Accepted

  Published as AU-B-2005214153

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005214154-Sulfonamide derivatives for the treatment of diseases

2005214150-Equipment for the biological activated sludge treatment of waste-water and procedure for its operation